http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017501991-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2014-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017501991-A |
| titleOfInvention | Biologically active insulin derivatives |
| abstract | The first aspect of the present invention is: (A) human or animal insulin, or the A chain of an analog or derivative thereof; (B) human or animal insulin, or the B chain of an analog or derivative thereof; (C) said A One or more disulfide bonds between the chain and the B chain; and (D) an additional covalent bond L between the functional group of the amino acid in the A chain and the functional group of the amino acid in the B chain (the functional group At least one of which is an amino acid side chain functional group). A further aspect of the invention relates to pharmaceutical compositions comprising said single chain insulin derivatives and their therapeutic use. |
| priorityDate | 2013-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 267.